Lucio Laudadio
Lanciano, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer.
Journal: Clinical breast cancer
Published: January 07, 2019
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience.
Journal: Journal of cellular physiology
Published: October 10, 2018
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial.
Journal: The Lancet. Oncology
Published: November 14, 2017
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience.
Journal: Oncotarget
Published: March 07, 2017
Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective study.
Journal: Journal of cancer research and clinical oncology
Published: July 13, 2015
Identification of subgroups of early breast cancer patients at high risk of nonadherence to adjuvant hormone therapy: results of an Italian survey.
Journal: Clinical breast cancer
Published: April 23, 2014
Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer.
Journal: Breast cancer research and treatment
Published: August 15, 2013
Gemcitabine-induced posterior reversible encephalopathy syndrome: a case report.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: November 09, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026